SEC Form 4 · accession 0001437749-17-017451
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven P Bitler
Officer — Vice President, Technology
Period of report
Oct 19, 2017
Accepted (ET)
Oct 23, 2017 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $12.65 | Oct 19, 2017 | M | 7,500 | A | Nov 19, 2017 | Nov 19, 2024 | Common Stock | 7,500 | 27,500 | D |
| Right to Buy Restricted Stock Unit (RSU)F2,F1 | — | Oct 19, 2017 | M | 2,500 | A | — | Oct 19, 2020 | Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.
- F2The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.